Quattro Four-in-One

Quattro is a physician-compounded four-in-one liquid formulation for erectile dysfunction, taken as drops. It combines multiple active compounds — including PDE5 inhibitors such as tadalafil and sildenafil — in a single compounded preparation, allowing a licensed provider to tailor the combination and dosing based on your specific profile. PDE5 inhibitors work by blocking the phosphodiesterase type 5 enzyme, which promotes smooth muscle relaxation in the penile vasculature and increases blood flow in response to sexual stimulation. The liquid delivery format is an alternative to standard oral tablets and is designed for accurate, consistent dosing under physician direction. Your protocol — including the specific combination of actives and dosing — is determined entirely by your licensed telehealth provider.

The individual compounds in Quattro — including tadalafil and sildenafil — have decades of clinical research behind them. Sildenafil received FDA approval for erectile dysfunction in 1998; tadalafil in 2003. Both belong to the PDE5 inhibitor class and have been studied in thousands of clinical trials across a broad range of patient populations. Compounded multi-agent ED formulations allow licensed providers to prescribe combinations that aren't available in a single commercially manufactured product — giving patients access to individually tailored treatment. Quattro, as prescribed through OLIV Well, is compounded at an FDA-registered, 503A-compliant pharmacy and is not the same as any commercially branded product.

Quattro contains PDE5 inhibitors. Potential side effects common to this compound class include headache, flushing, nasal congestion, dyspepsia (indigestion), visual disturbances (typically transient, and which may include changes in colour perception), and dizziness or lightheadedness. Serious but less common effects can include sudden vision or hearing loss and priapism — a prolonged, painful erection requiring immediate medical attention. PDE5 inhibitors are contraindicated in patients taking nitrates or alpha-blockers and in patients with certain cardiovascular conditions. This is not a complete list. Your OLIV Well provider will review your health history before prescribing and will identify any contraindications specific to your situation.

Function: Quattro's active compounds inhibit PDE5, an enzyme that restricts blood flow in smooth muscle tissue. By blocking PDE5, the formulation promotes vasodilation and supports the physiological conditions required for erectile function in response to stimulation. The multi-compound formulation allows your provider to calibrate the treatment to your individual response profile. Benefit: ED is one of the most common — and least discussed — health issues among men. Telehealth removes the conversation nobody wants to have in person, and gives you access to a clinically compounded treatment tailored to your situation by a real provider. The whole process stays private. That's by design.